![]() (R)-Zunsemetinib structure
|
Common Name | (R)-Zunsemetinib | ||
---|---|---|---|---|
CAS Number | 1640282-44-5 | Molecular Weight | 513.92 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H22ClF2N5O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of (R)-Zunsemetinib(R)-Zunsemetinib is the inactive isomer of Zunsemetinib (HY-139553), and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1]. |
Name | (R)-Zunsemetinib |
---|
Description | (R)-Zunsemetinib is the inactive isomer of Zunsemetinib (HY-139553), and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1]. |
---|---|
Related Catalog | |
References |
[1]. Zunsemetinib (ATI-450) – Investigational oral MK2 pathway inhibitor |
Molecular Formula | C25H22ClF2N5O3 |
---|---|
Molecular Weight | 513.92 |